{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:53:51Z","timestamp":1789844031511,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00228-023-03596-z","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:02:20Z","timestamp":1701360140000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-4474","authenticated-orcid":false,"given":"Chiara","family":"Elli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Novella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"3596_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1517\/14740338.7.5.587","volume":"7","author":"C Sun-Edelstein","year":"2008","unstructured":"Sun-Edelstein C, Tepper SJ, Shapiro RE (2008) Drug-induced serotonin syndrome: a review. Exp Opin Drug Saf 7:587\u2013596. https:\/\/doi.org\/10.1517\/14740338.7.5.587","journal-title":"Exp Opin Drug Saf"},{"key":"3596_CR2","doi-asserted-by":"publisher","first-page":"g1626","DOI":"10.1136\/bmj.g1626","volume":"348","author":"NA Buckley","year":"2014","unstructured":"Buckley NA, Dawson AH, Isbister GK (2014) Serotonin syndrome. BMJ 348:g1626. https:\/\/doi.org\/10.1136\/bmj.g1626","journal-title":"BMJ"},{"key":"3596_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/15563650.2020.1839662","volume":"59","author":"S Prakash","year":"2021","unstructured":"Prakash S, Rathore C, Rana K, Prakash A (2021) Fatal serotonin syndrome: a systematic review of 56 cases in the literature. Clin Toxicol 59:89\u2013100. https:\/\/doi.org\/10.1080\/15563650.2020.1839662","journal-title":"Clin Toxicol"},{"key":"3596_CR4","doi-asserted-by":"publisher","unstructured":"Perananthan V, Buckley NA (2021) Opioids and antidepressants: which combinations to avoid. Australian Prescriber 44. https:\/\/doi.org\/10.18773\/austprescr.2021.004","DOI":"10.18773\/austprescr.2021.004"},{"key":"3596_CR5","doi-asserted-by":"publisher","unstructured":"Rojas-Fernandez CH (2014) Can 5-HT3 antagonists really contribute to serotonin toxicity? A call for clarity and pharmacological law and order. Drugs Real World Outcomes 1:3\u20135. https:\/\/doi.org\/10.1007\/s40801-014-0004-3","DOI":"10.1007\/s40801-014-0004-3"},{"key":"3596_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1526-4610.2009.01575.x","volume":"50","author":"PK Gillman","year":"2010","unstructured":"Gillman PK (2010) Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 50:264\u2013272. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01575.x","journal-title":"Headache"},{"key":"3596_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00228-023-03500-9","volume":"79","author":"F Elbarbry","year":"2023","unstructured":"Elbarbry F, Moshirian N (2023) Linezolid-associated serotonin toxicity: a systematic review. Eur J Clin Pharmacol 79:875\u2013883. https:\/\/doi.org\/10.1007\/s00228-023-03500-9","journal-title":"Eur J Clin Pharmacol"},{"key":"3596_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40264-014-0180-9","volume":"37","author":"H Pontes","year":"2014","unstructured":"Pontes H, Cl\u00e9ment M, Rollason V (2014) Safety signal detection: the relevance of literature review. Drug Saf 37:471\u2013479. https:\/\/doi.org\/10.1007\/s40264-014-0180-9","journal-title":"Drug Saf"},{"key":"3596_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13:519\u2013523. https:\/\/doi.org\/10.1002\/pds.1001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3596_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nbt.2113","volume":"30","author":"R B\u00f6hm","year":"2012","unstructured":"B\u00f6hm R, H\u00f6cker J, Cascorbi I, Herdegen T (2012) OpenVigil\u2013free eyeballs on AERS pharmacovigilance data. Nat Biotechnol 30:137\u2013138. https:\/\/doi.org\/10.1038\/nbt.2113","journal-title":"Nat Biotechnol"},{"key":"3596_CR11","doi-asserted-by":"publisher","first-page":"e0157753","DOI":"10.1371\/journal.pone.0157753","volume":"11","author":"R B\u00f6hm","year":"2016","unstructured":"B\u00f6hm R, von Hehn L, Herdegen T et al (2016) OpenVigil FDA - Inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications. PLoS ONE 11:e0157753. https:\/\/doi.org\/10.1371\/journal.pone.0157753","journal-title":"PLoS ONE"},{"key":"3596_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00228-011-1156-7","volume":"68","author":"F Montastruc","year":"2012","unstructured":"Montastruc F, Sommet A, Bondon-Guitton E et al (2012) The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur J Clin Pharmacol 68:767\u2013775. https:\/\/doi.org\/10.1007\/s00228-011-1156-7","journal-title":"Eur J Clin Pharmacol"},{"key":"3596_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","volume":"74","author":"J-L Faillie","year":"2019","unstructured":"Faillie J-L (2019) Case\u2013non-case studies: Principle, methods, bias and interpretation. Therapies 74:225\u2013232. https:\/\/doi.org\/10.1016\/j.therap.2019.01.006","journal-title":"Therapies"},{"key":"3596_CR14","doi-asserted-by":"crossref","unstructured":"Poluzzi E, Raschi E, Piccinni C et al (2012) Data mining techniques in pharmacovigilance: Analysis of the publicly accessible fda adverse event reporting system (AERS). In: Data mining applications in engineering and medicine. IntechOpen","DOI":"10.5772\/50095"},{"key":"3596_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10:483\u2013486. https:\/\/doi.org\/10.1002\/pds.677","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3596_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/bph.12362","volume":"171","author":"F Franconi","year":"2014","unstructured":"Franconi F, Campesi I (2014) Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol 171:580\u2013594. https:\/\/doi.org\/10.1111\/bph.12362","journal-title":"Br J Pharmacol"},{"key":"3596_CR17","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1001\/jama.2016.16201","volume":"316","author":"N Shehab","year":"2016","unstructured":"Shehab N, Lovegrove MC, Geller AI et al (2016) US Emergency Department visits for outpatient adverse drug events, 2013\u20132014. JAMA 316:2115\u20132125. https:\/\/doi.org\/10.1001\/jama.2016.16201","journal-title":"JAMA"},{"key":"3596_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bja.2019.08.010","volume":"124","author":"BA Baldo","year":"2020","unstructured":"Baldo BA, Rose MA (2020) The anaesthetist, opioid analgesic Drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth 124:44\u201362. https:\/\/doi.org\/10.1016\/j.bja.2019.08.010","journal-title":"Br J Anaesth"},{"key":"3596_CR19","doi-asserted-by":"publisher","first-page":"bbab347","DOI":"10.1093\/bib\/bbab347","volume":"22","author":"Y Noguchi","year":"2021","unstructured":"Noguchi Y, Tachi T, Teramachi H (2021) Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform 22:bbab347. https:\/\/doi.org\/10.1093\/bib\/bbab347","journal-title":"Brief Bioinform"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03596-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T10:02:55Z","timestamp":1707472975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03596-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3596"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03596-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest directly relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}